Drugmaker Novo Nordisk profits jump in diabetes scourge

May 2, 2018
Novo Nordisk is the world's leading insulin maker

Danish drugmaker Novo Nordisk, the world's leading insulin provider, on Wednesday reported a six percent jump in net profit in the first quarter, as the global onslaught of diabetes continued to grow.

The group saw its grow to 10.7 billion kroner (1.44 billion euros, $1.72 billion) even as its sales decreased by five percent in Danish kroner year-on-year, reflecting a depreciation of the US dollar.

Novo Nordisk, which holds 46 percent of the world's insulin market share, is performing well thanks to a global scourge.

According to the World Health Organization, the number of people with diabetes has soared from 108 million in 1980 to 422 million in 2014.

The global prevalence of diabetes among adults has nearly doubled during that time, to 8.5 percent.

WHO has estimated 1.6 million deaths around the world were directly caused by diabetes in 2015, while another 2.2 million deaths were linked to in 2012.

For 2018, Novo Nordisk expects sales to grow by three to five percent in local currency, compared with two to five percent as previously announced.

The vast majority—84 percent—of the company's sales were in diabetes medication, including the flagship Tresiba insulin drug and Victoza, which is similar to insulin.

The rest came from treatments for haemophilia and growth hormones, for which Novo Nordisk saw its sales decrease by three and 10 percent respectively.

During the same period, the European and Japanese authorities granted the drugmaker authorisation for Ozempic, its new medication for type-2 diabetes.

The treatment was launched in the United States in February.

Explore further: Novo Nordisk raises profit forecast as earnings jump

Related Stories

Novo Nordisk raises profit forecast as earnings jump

October 29, 2015
The world's largest insulin maker, Novo Nordisk, raised Thursday its annual profit guidance after net profit jumped by 29 percent in the third quarter.

Novo Nordisk says US launch 'encouraging' as profit drops

April 29, 2016
The world's largest maker of diabetes treatments, Novo Nordisk, said on Friday that the US launch of ultra-long acting insulin Tresiba had been "encouraging" as it reported a drop in first quarter profit.

Insulin gives Denmark's Novo Nordisk a Q1 boost

May 1, 2013
(AP)—Danish pharmaceutical company Novo Nordisk A/S says first-quarter net profit rose 28 percent on strong sales of its diabetic drugs.

Novo Nordisk shares drop amid US pricing concerns

August 5, 2016
Shares in the world's largest maker of diabetes treatments, Novo Nordisk, fell more than eight percent on Friday after the company said prices were under pressure in the United States and lowered its growth forecast.

Danish Novo Nordisk profit surges

January 31, 2013
Danish pharmaceutical company Novo Nordisk A/S on Thursday reported a 23 percent growth in fourth-quarter net profit on strong sales of diabetic drugs and gave a positive outlook as regulators worldwide begin to approve its ...

Novo Nordisk cuts profit forecast amid US challenges

October 28, 2016
Shares in the world's largest maker of diabetes treatments, Novo Nordisk, fell by more than 19 percent on Friday after it cut its profit forecast, reflecting tough competition in the US market.

Recommended for you

Tongue-in-cheek Nobels honor nutritional analysis of cannibalism, roller-coaster kidney stones treatment

September 14, 2018
A nutritional analysis of cannibalism and treating kidney stones on roller-coasters were research projects honored by tongue-in-cheek awards at Harvard University Thursday, designed to make you laugh first, and think later.

Pediatric robot patient offers new level of realism for doctors in training

September 10, 2018
A team of researchers and engineers at Gaumard Scientific has unveiled a new robot that raises the bar on medical training devices. The robot, called HAL, has been made to look like a five-year-old male patient and offers ...

Why men say they've had more lifetime sexual partners than women

July 25, 2018
The disparity between the number of sexual partners reported by men and women can largely be explained by a tendency among men to report extreme numbers of partners, and to estimate rather than count their lifetime total, ...

Censors jump into action as China's latest vaccine scandal ignites

July 22, 2018
Chinese censors on Sunday deleted articles and postings about the vaccine industry as an online outcry over the country's latest vaccine scandal intensified.

Revenge of a forgotten medical 'genius'

June 30, 2018
It's not an uncommon fate for a pioneering scientist: languishing unrecognised in his time before dying in obscurity. But as his 200th birthday approaches, the life-saving work of a Hungarian obstetrician is finally getting ...

Yes, you can put too much chlorine in a pool

June 2, 2018
(HealthDay)—Before you take a dip in the pool this summer, be sure there's not too much chlorine in the water.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.